Characteristics and outcomes of adverse events after COVID‐19 vaccination

OBJECTIVES: BNT‐162b2, mRNA‐1273, and Ad26.COV2.S vaccines data regarding adverse events (AEs) are scarce. In this report, we aimed to describe fatal and non‐fatal possible AEs after COVID‐19 vaccine administration. METHODS: An observational multicenter study investigating the causes of emergency de...

Descripción completa

Detalles Bibliográficos
Autores principales: Kewan, Tariq, Flores, Monica, Mushtaq, Komal, Alwakeel, Mahmoud, Burton, Robert, Campbell, James, Perry, Hunter, Al‐Jaghbeer, Mohammed, Abi Fadel, Francois
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514147/
https://www.ncbi.nlm.nih.gov/pubmed/34693399
http://dx.doi.org/10.1002/emp2.12565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514147/
https://www.ncbi.nlm.nih.gov/pubmed/34693399
http://dx.doi.org/10.1002/emp2.12565

Ejemplares similares